Milton C. Weinstein

Henry J. Kaiser Professor of Health Policy and Management
Health Policy and Management
Harvard School of Public Health

Professor of Medicine
Harvard Medical School
Academic Director, CHDS
Home page:
PubMed Publications

Milton C. Weinstein, Ph.D., is the Henry J. Kaiser Professor of Health Policy and Management and Professor of Biostatistics at the Harvard School of Public Health and Professor of Medicine at the Harvard Medical School.  At the Harvard School of Public Health he is Academic Director of the Center for Health Decision Science and Faculty Chair of the Comparative Effectiveness Research Initiative.  He is best known for his research on cost-effectiveness of medical practices and for developing methods of economic evaluation and decision analysis in health care.  He is a co-developer of the CEPAC (Cost-Effectiveness of Preventing AIDS Complications) computer simulation model, and has conducted studies on prevention and treatment of HIV infections.  He was the co-developer of the Coronary Heart Disease Policy Model, which has been used to evaluate the cost-effectiveness of cardiovascular prevention and treatment.  He is an author of four books: Decision Making in Health and Medicine: Integrating Evidence and Values; Cost-Effectiveness in Health and Medicine, the report of the Panel of Cost Effectiveness in Health and Medicine; Clinical Decision Analysis; and Hypertension: A Policy Perspective.  He has also published more than 300 papers in peer-reviewed medical, public health, and economics journals.  He consults with industry and government and is a Principal Consultant with Optuminsight.  He is an elected member of the Institute of Medicine of the National Academy of Sciences, and a recipient of the Award for Career Achievement from the Society for Medical Decision Making and the Avedis Donabedian Lifetime Achievement Award from the International Society for Pharmacoeconomics and Outcomes Research.  Dr. Weinstein received his A.B. and A.M. in Applied Mathematics (1970), his M.P.P. (1972), and his Ph.D. in Public Policy (1973) from Harvard University.

Global HIV/AIDS Policy Modeling

Identifying the most effective treatment strategies for HIV infection in less developed countries

Predicting Cardiovascular Disease Risk in India and South Africa

Evaluating strategies for assessing cardiovascular risk

HIV/AIDS Policy Modeling for the U.S.

Addressing critical HIV/AIDS-related clinical and policy questions within the U.S.

Cardiovascular Disease Policy Model

A model focused on screening, prevention and treatment of CVD

Medical Spending and Health Outcomes

Should the U.S. be using cost effectiveness analysis with regards to medical expenditures?